Do Ashkenazi Jews hold the key to a long life?
Aging experts are studying a group of Ashkenazic centenarians. Photo by Cometary / iStockPhoto
By David Ian Klein March 10, 2021
A fountain of youth doesn’t exist, but scientists are researching whether a drug known for treating malaria could actually delay the aging process. That was just one of the myriad topics discussed in a Zoominar hosted by the Forward on Wednesday.
“It was noticed during the 70 years of use that people on metformin don’t develop diabetes, don’t develop cardiovascular disease, don’t develop cancers, don’t develop Alzheimer’s and don’t there are a variety of studies which show that,” Dr. Nir Barzilai explained during the hour-long event moderated by Rob Eshman, the national editor at the Forward.
Barzilai, the director of the Einstein Institute for Aging Research at Yeshiva University, is planning to study the drug’s effect on elderly populations to discover if it only prevents certain diseases or if it significantly affects aging itself, and thus all of its related diseases.
The greatest risk factor for common diseases, said Barzilai, is age. It makes much more sense to slow that process than to try to treat individual diseases.
Barzilai was joined on the panel by Dr. Sofiya Milman, the director of Human Longevity Studies at the Einstein Institute for Aging Research.
The focus of their research study, the largest of its kind in the world, are Ashkenazi Jews who live to 100 years old or more. The doctors made clear that Ashkenazim were selected not because they have a higher propensity to live longer, but because of their contained gene pool — and because so many of them live near the Einstein Institute. (A New York Magazine cover article touting their research was titled: What do a bunch of old Jews know about living forever?)
Often, when centenarians pass away, their survivors point to unique diets or even eccentric habits as the source of their long life. In contrast, what Milman and Barzilai found is that genetics matter more.
Medicine, mental health and lifestyle changes can help get those without the right genes a few extra years, said Barzilai. “You need to have something inherited to get to that age.”
Of course, that doesn’t mean elderly people without good genes should dump their vitamins and gym memberships.
“There’s always an interaction between your environment and your genes,” Milman said. “If someone doesn’t have the genes to overcome their bad environment, then it is absolutely imperative to avoid doing all the right things and not smoke, exercise and eat right.”
Milman added: “Until we can patent those genes as a drug, we should all continue our daily exercise.”
The Zoominar – “How to Die Young at a Very Old Age” – is just the latest in a series of virtual events hosted by the Forward in the past year since the pandemic forced in-person gatherings to be held online. Other talks in the series included a discussion on the demise of the Jewish deli and a look at the complex relationships among the Black and Jewish communities. All of the videos, including chats with members of our “Forward 50” list, can be found on the Forward’s YouTube channel.
Watch the entire talk from Wednesday below:
This is a moment of great uncertainty. Here’s what you can do about it.
We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover.
This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.
With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.
The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.
Support our mission to tell the Jewish story fully and fairly.
